Approach to relapsed CLL including Richter Transformation

被引：2
|
作者：
Seymour, John F. [1 ,2 ]
机构：
[1] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Haematol, 305 Grattan St, Melbourne, VIC 3000, Australia
来源：
HEMATOLOGICAL ONCOLOGY | 2023年 / 41卷
关键词：
acalabrutinib; chronic lymphocytic leukemia; ibrutinib; relapse; Richter transformation; treatment sequencing; Venetoclax; zanubrutinib; CHRONIC LYMPHOCYTIC-LEUKEMIA; VENETOCLAX PLUS RITUXIMAB; OPEN-LABEL; MUTATIONS; MECHANISMS; IDELALISIB; RESISTANCE; SURVIVAL; EFFICACY; THERAPY;
D O I：
10.1002/hon.3146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：136 / 143
页数：8
相关论文
共 50 条
  • [21] Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
    Kittai, Adam S.
    Huang, Ying
    Miller, Sarah
    Allan, John N.
    Bhat, Seema A.
    Bond, David A.
    Brander, Danielle M.
    Byrd, John C.
    Chavez, Julio C.
    Chong, Elise
    Davids, Matthew S.
    Danilov, Alexey V.
    Ding, Wei
    Dowling, Mark R.
    Dvorak-Kornaus, Kaitlyn
    Freedman, Hannah
    Hampel, Paul J.
    Ho, Carrie
    Hwang, Steven R.
    Islam, Prioty
    Malakhov, Nikita
    Matasar, Matthew
    Miller, Cecelia
    Omer, Zulfa
    Parikh, Sameer A.
    Parry, Erin
    Rabe, Kari G.
    Raess, Philipp W.
    Rai, Manoj
    Roeker, Lindsey
    Rhodes, Joanna
    Rogers, Kerry A.
    Saha, Aditi
    Schade, Jake
    Scott, Hamish W.
    Shadman, Mazyar
    Shouse, Geoffrey
    Skarbnik, Alan
    Spurgeon, Stephen
    Stephens, Deborah M.
    Thompson, Meghan C.
    Thompson, Philip A.
    Wang, Yucai
    Yano, Max
    Woyach, Jennifer A.
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [22] U-RT1-A new model for Richter transformation
    Schmid, Teresa
    Maier, Julia
    Martin, Melanie
    Tasdogan, Alpaslan
    Tausch, Eugen
    Barth, Thomas F. E.
    Stilgenbauer, Stephan
    Bloehdorn, Johannes
    Moeller, Peter
    Mellert, Kevin
    NEOPLASIA, 2021, 23 (01): : 140 - 148
  • [23] Richter Transformation of Chronic Lymphocytic Leukemia in the Era of Novel Agents
    Wang, Yucai
    Ding, Wei
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (06) : 348 - 357
  • [24] Descriptive analysis of genetic aberrations and cell of origin in Richter transformation
    Chitalia, Ami
    Swoboda, David M.
    McCutcheon, Justine N.
    Ozdemirli, Metin
    Khan, Nadia
    Cheson, Bruce D.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 971 - 979
  • [25] Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL
    Maurer, C.
    Langerbeins, P.
    Bahlo, J.
    Cramer, P.
    Fink, A. M.
    Pflug, N.
    Engelke, A.
    von Tresckow, J.
    Kovacs, G.
    Stilgenbauer, S.
    Wendtner, C-M
    Mueller, L.
    Ritgen, M.
    Seiler, T.
    Fischer, K.
    Hallek, M.
    Eichhorst, B.
    LEUKEMIA, 2016, 30 (10) : 2019 - 2025
  • [26] Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies
    Pflug, Natali
    Chakupurakal, Geothy
    Fink, Anna-Maria
    Robrecht, Sandra
    Herling, Marco
    Cramer, Paula
    Holtick, Udo
    Theurich, Sebastian
    Schetelig, Johannes
    Fischer, Kirsten
    Ritgen, Matthias
    Scheid, Christof
    Eichhorst, Barbara
    Dreger, Peter
    Hallek, Michael
    von Bergwelt-Baildon, Michael
    HEMASPHERE, 2021, 5 (12):
  • [27] The molecular map of CLL and Richter's syndrome
    Sud, Amit
    Parry, Erin M.
    Wu, Catherine J.
    SEMINARS IN HEMATOLOGY, 2024, 61 (02) : 73 - 82
  • [28] The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
    Flinn, Ian W.
    Hillmen, Peter
    Montillo, Marco
    Nagy, Zsolt
    Illes, Arpad
    Etienne, Gabriel
    Delgado, Julio
    Kuss, Bryone J.
    Tam, Constantine S.
    Gasztonyi, Zoltan
    Offner, Fritz
    Lunin, Scott
    Bosch, Francesco
    Davids, Matthew S.
    Lamanna, Nicole
    Jaeger, Ulrich
    Ghia, Paolo
    Cymbalista, Florence
    Portell, Craig A.
    Skarbnik, Alan P.
    Cashen, Amanda F.
    Weaver, David T.
    Kelly, Virginia M.
    Turnbull, Barry
    Stilgenbauer, Stephan
    BLOOD, 2018, 132 (23) : 2446 - 2455
  • [29] Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies
    Maliha Khan
    Rabbia Siddiqi
    Philip A. Thompson
    Annals of Hematology, 2018, 97 : 1 - 15
  • [30] Anisolymphocytosis: A clue for Richter transformation
    Manabe, Masahiro
    Inano, Naoyuki
    Hagiwara, Yuuji
    Nanno, Satoru
    Koh, Ki-Ryang
    CLINICAL CASE REPORTS, 2024, 12 (05):
12345